Literature DB >> 31130280

Growth differentiation factor 15 and geriatric conditions in acute coronary syndrome.

Juan Sanchis1, Vicente Ruiz2, Clara Bonanad3, Clara Sastre3, Arantxa Ruescas4, Macarena Díaz5, Enrique Rodríguez5, Ernesto Valero3, Sergio García-Blas3, Arturo Carratalá5, Eduardo Núñez3, Julio Núñez3.   

Abstract

BACKGROUND: Growth differentiation factor 15 (GDF-15) is a marker of cell senescence. Age is a well-known determinant of GDF-15 levels, yet no study has analyzed the relationship between geriatric conditions and GDF-15. We hypothesize that geriatric conditions reflecting biological age might be stronger determinants of GDF-15 than chronological age in elderly patients with acute coronary syndrome.
METHODS: A total of 208 patients (mean age = 78.3 ± 7.0 years) were included. Prior to discharge, a thorough geriatric assessment was performed and GDF-15 measured. Predictors of GDF-15 (transformed by its natural logarithm) were determined with linear regression. Furthermore, Cox regression was used for the analysis of all-cause mortality. The median follow-up was 728 days.
RESULTS: Median GDF-15 concentration was 2432 pg/ml. In multivariate analysis, frailty (Fried score, p = 0.001), and comorbidity (Charlson index, p = 0.003) were independent determinants of lnGDF-15 while age was not significant (p = 0.17). Other covariates included in the model were male gender (p = 0.017), diabetes (p = 0.169), Killip class ≥2 (p = 0.046) and glomerular filtration rate (p = 0.001). The Fried score and Charlson index provided significant incremental value in the R2 model (0.362 vs 0.447; p = 0.0001). A total of 66 (32%) patients died. LnGDF-15 was a significant mortality predictor (HR = 1.82, 95% CI 1.12-2.94, p = 0.015) along with the Fried score (p = 0.013) and the Charlson index (p = 0.030).
CONCLUSIONS: Geriatric conditions are strong determinants of GDF-15 levels on top of age in acute coronary syndromes. Furthermore, GDF-15 was associated with mortality independently of geriatric status. Geriatric assessment and GDF-15 are complementary tools.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute coronary syndrome; Elderly; Growth differentiation factor 15

Mesh:

Substances:

Year:  2019        PMID: 31130280     DOI: 10.1016/j.ijcard.2019.05.034

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Is an MRI-derived anatomical measure of dementia risk also a measure of brain aging?

Authors:  Ramon Casanova; Andrea M Anderson; Ryan T Barnard; Jamie N Justice; Anna Kucharska-Newton; Beverly Gwen Windham; Priya Palta; Rebecca F Gottesman; Thomas H Mosley; Timothy M Hughes; Lynne E Wagenknecht; Stephen B Kritchevsky
Journal:  Geroscience       Date:  2022-09-02       Impact factor: 7.581

Review 2.  GDF15: A Hormone Conveying Somatic Distress to the Brain.

Authors:  Samuel M Lockhart; Vladimir Saudek; Stephen O'Rahilly
Journal:  Endocr Rev       Date:  2020-08-01       Impact factor: 19.871

3.  Changes in systemic GDF15 across the adult lifespan and their impact on maximal muscle power: the Copenhagen Sarcopenia Study.

Authors:  Julian Alcazar; Ulrik Frandsen; Tatyana Prokhorova; Rikke S Kamper; Bryan Haddock; Per Aagaard; Charlotte Suetta
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-10-06       Impact factor: 12.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.